SHOX2 and cholangiocarcinoma: DNA from plasma samples taken preoperatively from 20 cholangiocarcinoma patients, and 100 matched controls was analyzed for relative SHOX2 and SEPT9 DNA methylation (see Additional file 2: Table S1 for clinicopathological characteristics of both cohorts).